Issue of Options, Salary Waivers, Incentive Plan

AI SummaryClose X

Cizzle Biotechnology Holdings Plc announced the conditional grant of new performance-related share options to directors, subject to shareholder approval at the upcoming AGM, as compensation for extended salary waivers. These new options are tied to achieving key milestones such as US laboratory accreditation, new commercial licensing agreements, operational profit, and securing £1 million in new revenues or royalties. Following these grants, the total number of ordinary shares under option will be 59,458,766, representing 15.00% of the company's current issued ordinary share capital.

Disclaimer*

UK 100

Latest directors dealings